For children with febrile urinary tract infection (UTI), stopping antibiotic treatment 3 days after clinical improvement ...
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
The FDA has approved the drug for use in women and girls over the age of 12 who suffer from uncomplicated urinary tract ...
the frontline antibiotic which is currently used to treat UTIs. Its main side effects were diarrhea, which affected 16% of patients in the clinical trial, and nausea, which affected 9% of ...
a common UTI antibiotic. In one study, slightly more people got better with Blujepa (50.6% vs. 47.0%), while in another, Blujepa was much more effective (58.5% vs. 43.6%). Side effects are ...
Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...